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Abstract: 
Charcot foot is a rare but a serious diabetic related condition. Usually it is 
misdiagnosed although its prognosis related to timely and proper management  
Objective: To study the management and outcome of diabetic Charcot’s foot in 
Jabir AbuEliz diabetic center in period between 2012 and 2019 
Methods: A combined retro-prospective descriptive analytical study and hospital 
based. Study conducted to 134 diabetic patients with charcot joint attended to 
JADC during the study period. The study sample was calculated by total 
coverage. Study questionnaires captured mainly quantitative data. Data analyzed 
by using SPSS version 21. 
Results: 134 diabetic patients with charcot joint were involved in this study, most 
of the patients were males, in the age group 51-60 years and had NIDDM 
associated with other medical disorders.  At the time of presentation, 91% of the 
patients presented with swelling and 53.7% of the patients had pain. On 
examination of the foot; 84.3% of the patients had swelling and 59.7% of the 
patients had dry skin. Hammer toes deformity was the commonest feet deformity. 
Based on modified Sella and Barrette classification, 17.2% of the patients in grade 
1. Casting was performed to all patients with good outcome to 91.1% of the 
patients  
Conclusion: This study reveals that grade 0,1&2 Charcot neuroarthropathy feet 
had good outcome if properly recognized and early managed. The total contact 
cast (TCC) and CAM walker is effective in the management. 
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Charcot arthropathy or Charcot joint is a progressive condition of musculoskeletal 
system that is characterized by joint dislocation, pathological fracture and 
debilitating deformity. Syphilis was believed to be the most common cause of 
Charcot arthropathy until 1936, when Jordan linked it to diabetes (the most 
common cause of Charcot joint now).
(1,2)
 
Charcot arthropathy results in progressive  destruction of bone and soft tissue at 
weightbearing joint. It can occur at any joint but most commonly in the lower 
extremity.The incidence of Charcot arthropathy is 0.1 to 5% in diabetic 
neuropathy. The prevalence of Charcot neuroarthropathy ranges from 0.08 to 
8.5%.
(3,4)
Charcot arthropathy is more common unilaterally, it can involve both 
lower limbs in 39%.
(5)
 
Pathophsiology of Charcot joint is unknown till now but there are two major 
theories: neurotraumatic and neurovascular.
(6)
  
The clinical presentation and symptoms of Charcot arthropathy  can range from 
mild swelling, mild deformity to sever deformity and significant swelling. Pain is 
the presenting symptom in some cases. Instability and loss of joint function also 
may be present. The incidence of ulceration is 17% per year.
(7)
 
On examination the signs of inflammation  are present. Unilateral swelling with 
an increase in local skin temperature, erythema, joint effusion and bone resorption 
in an insensate foot are present. Usually the skin is intact the protective sensation  
is lost. The increase in local skin temperature in affected sites increased by ( > 
2degree) above unaffected foot's skin temperature. 
Sella and Barrette develop a five stage classification scheme based on 
radiographs, clinical findings and bone scan.
(8)
 
Laboratory studies included complete haemogram & ESR, CRP, renal function 
with electrolyte, blood glucose level, HA1C and serum calcium. Imaging studies 
include plain radiograph and in some cases MRI.
(9)
 
In medical  treatment once the process is recognized it should be treated via the 
VIPs(vascular management, infection management, prevention and pressure 
relief).
(10)
The aim of treatment is Pressure relief or off loading and immobilization 
with total contact cast(TCC)which helps prevent joint destruction. In some 
situations uses of control ankle motion walker is of value. Many surgical 
procedures and techniques were used in treatment of Charcot joint depending on 
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location of the disease and surgeon’s experience with the condition. For example: 
osteotomy, arthrodesis, screw & plate fixation, open reduction and internal 
fixation, reconstructive surgery  and amputation. 
 
 Methods : 
A cohort prospective study was conducted between April 2012 and June  2019 in 
Jabir AbuEliz Diabetic Center (JADC), Khartoum, Sudan. It included 134 diabetic 
patients with Charcot arthropathy (study group). All patients had an informed 
consent, and the study was approved by the ethical committee in JADC. 
All patients who presented to our outpatient clinic with diabetic Charcot 
arthropathy underwent clinical, laboratory and imaging studies. The data were 
collected using a predesigned  form and included the history, physical 
examination, investigations and management. The patients were followed up 
regularly in the foot clinic. 
Clinical assessment included  the signs of inflammation, swelling with an increase 
in local skin temperature, erythema, joint effusion and bone resorption in an 
insensate foot . The increase in local skin temperature in affected sites increase 
(more than 2 degree) above unaffected foot’s skin temperature using hand held 
infrared thermometry. Vibrating tuning fork and 10g Semmes Weinstein 
monofilament and position sense  were used to evaluate presence of neuropathy. 
Probe-to-bone test was performed using a sterile probe to palpate the suspicious 
osteomylitic bone at the base of ulcer or sinus if present. Vascular assessment 
through clinical examination, hand held doppler and ankle brachial pressure 
index. Duplex ultrasound and ankle brachial index were also used. 
Laboratory studies included complete haemogram with ESR, CRP, renal function 
with electrolyte, blood glucose level, HA1C and serum calcium. 
Imaging studies included plain radiographs to help stage disease, to determine  
stability of joint, subluxations, osteopenia, destruction and fractures. Magnetic 
Resonance imaging (MRI)was used selectively when there was no correlation 
between clinical pictures and plain radiograph. The classification of Charcot 
arthropathy based on modified Sella and Barrette staging. Sella and Barrette 
developed a five stages classification scheme based on radiographs, clinical 
findings and bone scan. We modified the classification by adding fractures and 
osteomylitis : 
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Stage 0 : consist of localized heat and swelling of medial column, radiographs are 
normal 
Stage 1 : early bone involvement is seen in radiographs (localized osteopenia, 
subchondral cyst & erosion) 
Stage 2 : consist of joint subluxation 
Stage 3 : consist of dislocation & joint collapse  
Stage 4 : presence of fractures  
Stage 5 : presence of osteomylitis 
Stage 6 : represents healing & radiographic findings include sclerosis and fusion 
of affected  bone or joint  
Another common used classification system is the Brodskey and Rouse system. It 
describes three anatomical Charcot : 
- Type 1 involves the midfoot 
- Type 2 involves the hind foot 
- Type 3 involves the ankle 
The foot can be divided into the hindfoot, midfoot and forefoot. Hindfoot  
composed of the talus and calcaneus. Midfoot composed of the cuboid, 
navicular and 3 cuneiform. Forefood composed  of the 5 toes and 5 metatarsal 
bones. Tibia and fibula connected to talus bone to form the ankle joint. 
The treatment consist of Total Contact Cast of affected limb. Cast was checked 
every 2 weeks to evaluate for proper fit and changed if mandate. Serial plain 
radiographs were taken approximately every 2-4 weeks. Casting usually 
discontinued on the basis of clinical, radiological and dermal thermometric signs 
of quiescence. If the difference between Charcot limb and normal limb is less than 
2 degrees based on hand held thermometer, the cast is replaced by controlled 
ankle motion(CAM) walking boot. The idea was to mobilize the patients in 
quiescence Charcot to minimize disuse atrophy that occurred with prolonged 
contact cast. 
The data were analyzed using the SPSS program version 20. Statistical tests using 
student’s t-test for numerical values and Chi square (x2) tests were utilized. A P 
value was considered significant when it was > 0.05. 
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A total of 134  diabetic patients with Charcot  arthropathy were included. Males 
88 (65.7%) were  affected more than females 46 (34.3%) of the patients. The 
majority of the patients had NIDDM 118 (88.1%). The duration of diabetes 
ranged between 11-15 years. The patients who depended on oral hypoglycemic 
control account for 44 (32.8%) and 89 (66.4%) depended on insulin. The majority 
had no renal complication but eye complication in the form of cataract 20 
(14.9%), retinopathy 27 ( 20.1%) and blindness 4 ( 3%) Table (1) . The chief 
complains at time of presentation in all cases was swelling in 122 of 
patients(91%),pain in 72 (53.7%) and fever just in 19 (14.2%). The cause was 
unknown in about  109 (81.3%) of the patients. Tight shoes, thermal injuries and 
sharp injuries accounted for small percent Table (2). 
On examination just (4%) of the patients were febrile, swelling presented in 113 
(84.3%) of the patients, 80 (59.7%) had dry skin, callus was obvious just in 25 
(18.7%) and about 97% of all patients had Charcot  joint deformity. Small number 
of the patients had hammer toes 17 (12.7%), pes cavus 2 (1.5%), pus planus 9 
(6.7%) and crowded toes in 15 (11.2%). 
Depending on the hand held thermometry the difference between Charcot joint 
and normal limb was more than 2 degrees in 106 (79.1%) of the patient.  
The vascular assessment of all patients were normal. The vibration sense was 
impaired in about 55(41 %) in both limbs, absent in 31(23.1%) and intact in 
48(35.8%) of  the patients Table (3). 
The sensation examination using 10 g monofilament was intact in 44 (32.8%), 
impaired in 57 ( 42.5%) and absent in 32 (23.8%) bilaterally. 
The position sense was intact in 88 (65.6%), impaired in 36 (26.8%) and absent in 
10 (7.4%) in both limb 
The classification of Charcot joint in this study depended on modified Sella and 
Barrette classification. The large percent in grade 1, 23 (17.1%) of the patients 
and grade 3&4, about 20 (14.9%) of the patients. According to the anatomical 
classification, the hind foot including ankle joint was involved in 59 (44.02%), 
mid foot was involved in 42 (31.3%) and fore foot was invoved in 33 (24.6) Table 
(5)  
At the time of presentation about  18 (13.4%) of the patients  had osteomylitis  
and 21 (15.7%) presented with fracture.  
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All patients underwent casting. The time duration of casting ranged between 3-6 
months. The outcome was 122 (91.04%) of the patients healed without 
complication,  4 (2.98%) developed minor amputation, 1 (0.74%)developed major 
amputation, 3 (2.23%) developed deformity in form of loss of the medial arch, 3 
(2.23%) died and 1 (0.74%) developed ulcer Table (6).  
Table (1):Demographic characteristics of 134 patients with Charcot joint 
Number of patients Characteristic 
















23.1% of patient 
23.1% of patient 

















Ischemic heart disease 






No renal impairment  
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Table (2):Symptoms, signs and deformities of 134 diabetic patients at the 
time of presentation: 
Number of patients  Symptoms: 
72 (53.7%) Pain 
19 (14.2%) Fever 
8 (6%) Malaise 
122 (91%) Swelling  
2 (1.5%) Discharge 
4(3%) Discoloration 
 Signs: 
4 (3%) Febrile 
2 (1.5%) Toxic 
8 (6%) Pale 
2 (1.5%) Confusion  
1 (0.7%) Dehydration  
80 (59.7%) Dry skin 
37 (27.6%) Fissures  
25 (18.7%) Callus  
113 (84.3%) Swelling  
1 (0.7%) Necrosis  
2 (1.5%) Puss  
0 Gangrene  
0 Prominent vein 
 Deformities 
7 (5.2%) Claw foot deformity 
9 (6.7%) Pes planus deformity 
2 (1.5%) Pes cavus deformity 
15 (11.2%) Crowded toes deformity 
15 (11.2) Hallux deformity 
17 (12.7%) Hammer toes deformity 
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Table (3):Vascular and neurological assessment of 134 diabetic patients with 
Charcot joint: 






85  (63.4 %) 
42 (31.3%) 
7  (5.2%) 
















12 ( 8.9%) 
0 
































 44 (32.2%) 
57 (42.5%) 
 33 (24.6%) 









 88 (65.6%) 
36 (26.8%) 
 10 (7.4%)  
 
 88 (65.6%) 
 36 (26.8%) 
10(7.4%) 
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Table (4):Extent of neuropathy in 134 diabetic patients with Charcot  joint 
after assessment: 


































Table (5):Modified Sella and Barrette classification in 134 diabetic patient 
with Charcot joint : 
Number of patient Grades 
18 (13.4%) 0  (localized heat and swelling, 
normal radiology) 
23 (17.1%) 1 ( localized osteopenia, subchondral 
cyst and erosion) 
18 (13.4%) 2 (joint subluxation) 
20 (14.9%) 3 (dislocation and joint collapse) 
21(15.6%) 4 ( fractures) 
18 (13.4%) 5 ( osteomylitis) 
16(11.9%) 6 ( quiescence) 
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Table (6):Outcome of 134 diabetic patients with Charcot joint underwent 
casting: 








Healing without complication 
Healing with minor amputation  
Healing with major amputation 





Table (7):The most affected anatomical site in the foot of 134 diabetic 
patients with Charcot joint: 






Hind foot including ankle joint 
 
Discussion: 
Diabetic foot arthropathy or Charcot joint in diabetes account for substantial 
morbidity, economic cost and time consuming in treatment. It is disabling and 
devastating condition. 
In our study we found that male was affected more than female by ratio of about 
2:1 (88:46), the mean age was 53 years, the majority of patients had NIDDM 118 
(88%), the mean duration of diabetes  was 15 years ( – or + 5 years). In 
comparison to astudy done in Ireland which showed the majority of patients were 
male (68%), the mean age was  58 years, most patients had type 2 diabetes 
mellitus and the main duration of diabetes was 15 years (-or+9 years).
(11)
 In our 
study 81.3% of patients did not recall any precipitating factors for Charcot joint in 
comparison to other a study which showed 73% of patients.
(12)
   
  The diagnosis was established after good history and clinical examination and 
radiological imaging. The main presenting symptom was swelling in 91% in 
comparison to a study that said the main reason for medical consultation in 
diabetic Charcot joint was persistent swelling.
(13)
 Some time the condition 
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associated with pain and fever in acute state.  
On examination the swelling accounted for 84.3% of symptoms and signs in 
comparison to a study which showed fever, swollen and tenderness were the main 
symptoms that made the differential diagnosis of acute gout, cellulites and deep 
vein thrombosis were there in acute presentation.
(14)
 The common observed 
presentation deformities in our study were hammer toes in (12.7%), hallux 
deformity in (11.2%) and pes planus deformity in (6.7%) in comparison to a study 




The presence of neuropathy was determined by clinical examination using 10g 
monofilament which is impaired in (42.5%) of the patients, 128 Hz tuning fork 
examination which was impaired in a bout (41%) and position sense impaired in 
about (26.8%) of the patient in comparison of a study showed  100% of patients 
had documented peripheral neuropathy.  7% of our patients had peripheral 
vascular disease in comparison to same last study which showed 2% of patient 
had peripheral vascular disease.
(11)
 
The gold standard to determine medical treatment in form of total contact cast 
(TCC) depended on hand held infrared thermometer. In our study the 79.1% of 
patient had difference of more than 2 C degree between Charcot joint and normal 
joint. In comparison to other  studies which showed that there was often a 
temperature difference between two feet of several degree.
(12,16)
 
The casting was continued until swelling resolved and temperature of affected 




The outcome after TCC was  91.04% of the patients healed without complication, 
2.98% developed minor amputation, 0.74% developed major amputation and 
0.74% developed ulcer due to cast. In comparison to a study showed 32% of 
patients healed without complication, 40% developed ulcer and 17 % required 
lower limb amputation in patient who received offloading treatment.
(11)
 
The time of healing of acute Charcot (quiescence phase) with TCC in the study 
was 3-6 months. In comparison to Armstrong study which revealed that the 
healing rate of Charcot joint in diabetic patients using TCC was 130 days(-or+74 
days.
(12)
 In other study the average time of healing was 86 days(-or+45 days).
(18)
   
Immobilization and offloading of diabetic Charcot joint remain the mainstays of 
therapy, other options are being tested for example Bisphosphonates which are 
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potent inhibitors of bone resorption. 
(19)
 However a few case reports have 
examined this treatment as an alternative.  
In our study the aim was to mobilize the patients early after acute Charcot's joint 
by supervised  Controlled Ankle Motion (CAM) walker.  
 
Conclusion: 
The use of Total contact cast and CAM walker reloading in the management of 
diabetic Charcot Joint enhances the healing and early quiescence 
 
References: 
1. kelly M. William Musgrave’s De Arthritide symptomatic (1703): His description 
of neuropathic arthritis. Bull Hist Med. 1963. 37:372-6 
2. Charcot JM. Sur quelaques arthropathies qui paraissent depender d’une lesion du 
cerveau ou de la moele epiniere. Arch Des physiol Norm et path. 1868. 1:161-71 
3. Brodsky JW, Rouse AM. Exostectomy for symptomatic bony prominences in 407 
diabetic charcot feet. Clin Orthop Relat Res 1993:21-26.408 6. 
4. Armstrong DG, Peters EJ. Charcot's arthropathy of the foot. J Am Podiatr Med 
409 Assoc 2002;92:390-394. 
5. Larsen K, Fabrin J, Holstein PE. Incidence and management of ulcers in diabetic 
417 Charcot feet. J Wound Care 2001;10:323-328 
6. LaFontaineJ,LaveryL,JudeE,CurrentConceptsofCharcot Footin Diabetic Patients, 
TheFoot(2015),http://dx.doi.org/10.1016/j.foot.2015.11.001 
7. Larsen K, Fabrin J, Holstein PE. Incidence and management of ulcers in diabetic 
417 Charcot feet. J Wound Care 2001;10:323-328 
8. Sella EJ, et al. Staging of charcot neuropathy along the medial column of the foot 
in the diabetic patient. J Foot Ankle Surg. 1999 Jan-Feb 
9. Schlossbauer T, Mioc T,Sommerey S, Kessler SB, Reiser MF, Pfeifer KJ. 
Magnetic resonance imaging early stage Charcot arthropathy: correlation of 
imaging finding and clinical symptoms. Eur J Med Res. 2008 sep22. 13(9):409-
14 
10. Snyder, R.J., et al., The management of diabetic foot ulcers through optimal off-
loading building consensus guidelines and practical recommendations to improve 
outcomes. J Am Podiatr Med Assoc, 2014. 104(6): p. 555-67 
11. O'Loughlin, A., Kellegher, E., McCusker, C. et al. Ir J Med Sci (2007) 186: 151. 
Doi:10.1007/s11845-016-1508-5 
12. Armstrong DG, Todd WF, Lavery LA, Harkless LB, Bushman TR (1997) The 
natural history of acute Charcot's arthropathy in adiabetic foot speciality clinic. 
Diabet Med 14:357-363 
13. Wilson M (1991) Charcot foot osteoarthropathy in diabetes mellitus. Mild Med 
156:563-569 
Gezira Journal of Health Sciences June 2020 Volume 16(1)________________ 
Gezira Journal of Health Sciences June 2020 Volume 16(1)  59 
 
 
14. Sinha SB, Munichoodappa CS, Kozak GP (1972)  Neuroarthopathy (Charcot 
joints ) in diabetes mellitus. Clinical study of 101 cases. Medicine (Baltimore) 
51:191-210 
15. Sella EJ, Barrette C (1991) Staging of Charcot neuroarthropathy along the medial 
column of foot in diabetic patient. J Foot Ankle Surg 38:34-40 
16. McGill M, Molyneaux L, Bolton T, Ioannou K, Uren R, Yue DK. Response of 
Charcot's arthropathy to contact casting: assessment by quantitative techniques. 
Diabetologia 2000;43:481-484 
17. Armstrong DG, Lavery LA. Monitoring healing of acute Charcot's arthropathy 
with infrared dermal thermometry. J Rehabil Res Dev 1997;34:317-321 
18. Sinacore DR. J Diabetes compilication. Acute Charcot arthropathy in patients 
with diabetes  mellitus: healing times by foot location. Sep-Oct 1998 
19. Selby PL, Young MJ, Boulton AJ. Bisphosphonates: a new treatment for diabetic 
Charcot neuroarthropathy?. Diabet Med. 1994 Jan-Feb. 11(1):28-31 
 
 
 
